I-fibrinogen as an oncophilic radiodiagnostic agent: Distribution kinetics in tumor bearing mice

Kenneth Krohn, S. J. DeNardo, D. W. Wheeler, G. L. DeNardo

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Fibrinogen radioiodinated by the iodine monochloride method was tested as a tumour radiodiagnostic agent in mice. The I-fibrinogen cleared from the blood of tumour-bearing mice more rapidly than from that of normal mice, but it cleared from the whole body more slowly, suggesting it accumulated in a substantial tumour-related compartment in the abnormal mice. The tumour concentration steadily increased for 4 h after injection, at which time it reached a peak concentration of 11.4% of the injected dose/g. This concentration was higher than the peak concentration for Ga-citrate (not reached until 24 h) or any other oncophilic radiopharmaceutical tested in this tumour model. The early accumulation is consistent with the use of 123I as a tracer label for fibrinogen. A combination of the large tumour concentration of I-fibrinogen, and increased catabolic rate induced by chemical modification, and the exceptional nuclear properties of 123I for scintigraphic imaging, could lead to a very useful radiodiagnostic procedure for cancer.

Original languageEnglish (US)
Pages (from-to)227-234
Number of pages8
JournalBritish Journal of Cancer
Volume36
Issue number2
StatePublished - 1977
Externally publishedYes

Fingerprint

Fibrinogen
Neoplasms
Radiopharmaceuticals
Citric Acid
Injections

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

I-fibrinogen as an oncophilic radiodiagnostic agent : Distribution kinetics in tumor bearing mice. / Krohn, Kenneth; DeNardo, S. J.; Wheeler, D. W.; DeNardo, G. L.

In: British Journal of Cancer, Vol. 36, No. 2, 1977, p. 227-234.

Research output: Contribution to journalArticle

Krohn, Kenneth ; DeNardo, S. J. ; Wheeler, D. W. ; DeNardo, G. L. / I-fibrinogen as an oncophilic radiodiagnostic agent : Distribution kinetics in tumor bearing mice. In: British Journal of Cancer. 1977 ; Vol. 36, No. 2. pp. 227-234.
@article{dc43caae30c5403c8f985ceeea11c3e6,
title = "I-fibrinogen as an oncophilic radiodiagnostic agent: Distribution kinetics in tumor bearing mice",
abstract = "Fibrinogen radioiodinated by the iodine monochloride method was tested as a tumour radiodiagnostic agent in mice. The I-fibrinogen cleared from the blood of tumour-bearing mice more rapidly than from that of normal mice, but it cleared from the whole body more slowly, suggesting it accumulated in a substantial tumour-related compartment in the abnormal mice. The tumour concentration steadily increased for 4 h after injection, at which time it reached a peak concentration of 11.4{\%} of the injected dose/g. This concentration was higher than the peak concentration for Ga-citrate (not reached until 24 h) or any other oncophilic radiopharmaceutical tested in this tumour model. The early accumulation is consistent with the use of 123I as a tracer label for fibrinogen. A combination of the large tumour concentration of I-fibrinogen, and increased catabolic rate induced by chemical modification, and the exceptional nuclear properties of 123I for scintigraphic imaging, could lead to a very useful radiodiagnostic procedure for cancer.",
author = "Kenneth Krohn and DeNardo, {S. J.} and Wheeler, {D. W.} and DeNardo, {G. L.}",
year = "1977",
language = "English (US)",
volume = "36",
pages = "227--234",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - I-fibrinogen as an oncophilic radiodiagnostic agent

T2 - Distribution kinetics in tumor bearing mice

AU - Krohn, Kenneth

AU - DeNardo, S. J.

AU - Wheeler, D. W.

AU - DeNardo, G. L.

PY - 1977

Y1 - 1977

N2 - Fibrinogen radioiodinated by the iodine monochloride method was tested as a tumour radiodiagnostic agent in mice. The I-fibrinogen cleared from the blood of tumour-bearing mice more rapidly than from that of normal mice, but it cleared from the whole body more slowly, suggesting it accumulated in a substantial tumour-related compartment in the abnormal mice. The tumour concentration steadily increased for 4 h after injection, at which time it reached a peak concentration of 11.4% of the injected dose/g. This concentration was higher than the peak concentration for Ga-citrate (not reached until 24 h) or any other oncophilic radiopharmaceutical tested in this tumour model. The early accumulation is consistent with the use of 123I as a tracer label for fibrinogen. A combination of the large tumour concentration of I-fibrinogen, and increased catabolic rate induced by chemical modification, and the exceptional nuclear properties of 123I for scintigraphic imaging, could lead to a very useful radiodiagnostic procedure for cancer.

AB - Fibrinogen radioiodinated by the iodine monochloride method was tested as a tumour radiodiagnostic agent in mice. The I-fibrinogen cleared from the blood of tumour-bearing mice more rapidly than from that of normal mice, but it cleared from the whole body more slowly, suggesting it accumulated in a substantial tumour-related compartment in the abnormal mice. The tumour concentration steadily increased for 4 h after injection, at which time it reached a peak concentration of 11.4% of the injected dose/g. This concentration was higher than the peak concentration for Ga-citrate (not reached until 24 h) or any other oncophilic radiopharmaceutical tested in this tumour model. The early accumulation is consistent with the use of 123I as a tracer label for fibrinogen. A combination of the large tumour concentration of I-fibrinogen, and increased catabolic rate induced by chemical modification, and the exceptional nuclear properties of 123I for scintigraphic imaging, could lead to a very useful radiodiagnostic procedure for cancer.

UR - http://www.scopus.com/inward/record.url?scp=0017727834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017727834&partnerID=8YFLogxK

M3 - Article

C2 - 911661

AN - SCOPUS:0017727834

VL - 36

SP - 227

EP - 234

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 2

ER -